SOUTHERN JOURNAL OF SCIENCES

Background: Determining chlorine in water ensures safety. Among other methods, the DPD colorimetric method is used. The DPD Method relies on colorimetric reactions to measure free and total chlorine concentration in water samples with pink compound formation. Aims: To perform a comparative chlorine analysis using DPD, assessing reagents from 3 makers and 2 Hach instruments to identify disparities and propose adjustments for more accurate measurements. Methods: Hach High-Range and Low-Range Free chlorine determination procedures were followed. DR300 and POCKET Colorimeter II spectrophotometers were used. Tests were conducted for each DPD manufacturer in low/high ranges and in two HACH devices to determine the chlorine concentrations. Hach was used as the reference; LaMotte and PoliControl compared against it. Statistical analyses were compiled using MS Excel. Results: The tests findings were gathered in Tables 1-5. JavaScript and HTML scripts were created to convert LaMotte and PoliControl outcomes into values equivalent to those of HACH through linear interpolation. Discussion: Various DPD reagents and equipment provided slightly different readings, prompting empirical evaluation of these differences. Adjusting the results to Hach's results was selected as both the reagent and spectrophotometer were from the same brand. Differences in spectrophotometer readings were more pronounced in high-range tests nearing the upper limit of the test. Conclusions: Equipment variations caused minor result differences; DPD reagents are not interchangeable without correlation. The Open-source code developed aided in reducing reading disparities.

Background: Industrial wastewater contains pollutants that are detrimental to human health in varied proportions. Among the pollutants are heavy metals, including Zn2+, Pb2+, and Cu2+ found in a characterized pharmaceutical wastewater. Several techniques have been proposed for the heavy metal sequester. However, they are with attendant challenges. The adsorption techniques using clay-metal oxide modified adsorbent/composite such as silver-clay adsorbent is considered suitable for an effective sequestering process. Aims: To develop and characterize Ag/clay adsorbent for pharmaceutical wastewater treatment. Methods: The Ag nanoparticles were synthesized using Parkia biglobossa aqueous leaves extract in an optimization study. The raw clay was beneficiated and doped with silver nanoparticles via the wet impregnation method. The silver-clay adsorbent was characterized using FTIR, XRD, SEM, and EDS characterization tools. The developed adsorbent was used for the batch adsorption process of the heavy metal ion removal from the wastewater. Results and Discussion: The phytochemical analysis and FTIR results of the P. biglobosa showed that the leaf contains phenol, tannin, and flavonoids which acts as reducing, capping, and stabilizing agent required for synthesizing the silver nanoparticles. The prepared silver nanoparticles modified clay adsorbent Ag/clay, have evenly distributed stacks of pseudo-hexagonal plates, are rich in silica, possess silver nanoparticles in the frameworks, and contain functional groups suitable for binding heavy metals. The adsorptions of Zn2+, Pb2+, and Cu2+ from pharmaceutical wastewater onto the silver-modified clay were studied as a function of adsorbent dosage and contact time. The percentage removal results obtained showed that the adsorbent had up to 99.96%, 99.5%, and 99.44% removal efficiency for Zn2+, Pb2+, and Cu2+, respectively, which are better compared with previous studies. The adsorption process was feasible, spontaneous, and exothermic, with Langmuir and Pseudo-second-order models as best fits for the process. Conclusions: The adsorption of selected heavy metal ions onto the green synthesized silver-modified clay adsorbent (Ag/clay) was feasible, spontaneous, and exothermic in the order Zn2+>Pb2+>Cu2+ with Langmuir and Pseudo-second-order model best fitted for the process. These show that the synthesized silver oxide nanoparticles supported on local clay can be used as a potentially low-cost adsorbent to remove heavy metal ions from industrial wastewater.

Background: β-thalassemia is a blood disorder in which the body does not make hemoglobin normally. Aim: To assess serum sclerostin in female patients with beta-thalassemia and compare with the healthy controls and to predict its complication associated with the bone pathophysiology, for designed improvement the lifestyle goodliness for these patients. Material and methods: Sixty-nine female beta-thalassemia (βT) patients (54 βT major and 15 βT Intermedia), aged 8-40 years who dependent on transfused blood, and 20 healthy controls were evaluated serum sclerostin, and was examined the relationship with hematological parameters RBC, Hb, PCV, WBC, PLT, BMI, splenic status, iron, and ferritin levels. The information of beta-thalassemia patients was collected and records by the questioner. Results: A significantly increased serum sclerostin level (mean 26.80±0.91) pg/ml was showed in βT patients compared with the healthy controls (10.03±0.68, p  smaller than  0.001) pg/ml. Furthermore, a significant decrease (p smaller than 0.05) of the sclerostin level was observed in β-thalassemia major compared to intermedia β-thalassemia patients. Serum sclerostin level revealed a significant increase in progress age; it is highest in the age group (30-40) year as compared with age group (8-18) and (19-29) year respectively. Sclerostin showed no associations with the RBC, Hb, PCV, and significantly positively correlated (p smaller than 0.05) with serum iron, ferritin levels, WBC, and PLT count. Significantly higher sclerostin levels in splenectomized and underweight groups were observed compared to unsplenectomized and normal-weight groups (p smaller than 0.05) of βT patients. Conclusions: Sclerostin plays an important role in beta-thalassemia patients and can serve as a biomarker associated with the bone pathophysiology and indicator to prevent the continuation of such serious diseases caused by iron overload in these patients.